Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

EOLS

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
12/26/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
12/26/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
12/13/20243:05PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
11/06/20244:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
11/06/20243:37PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
11/06/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
11/06/20243:05PMBusiness WireEvolus Reports Third Quarter 2024 ResultsNASDAQ:EOLSEvolus Inc
11/01/20247:00AMBusiness WireEvolus to Participate in Stifel 2024 Healthcare ConferenceNASDAQ:EOLSEvolus Inc
10/31/20241:02PMBusiness WireEvolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device RegulationNASDAQ:EOLSEvolus Inc
10/29/20247:00AMBusiness WireEvolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersNASDAQ:EOLSEvolus Inc
10/23/20247:00AMBusiness WireEvolus to Report Third Quarter Financial Results on November 6, 2024NASDAQ:EOLSEvolus Inc
10/11/20249:53PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
09/27/20248:00PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
09/06/20248:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20248:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20247:00AMBusiness WireEvolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024NASDAQ:EOLSEvolus Inc
09/04/20243:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
08/09/20243:30PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
07/31/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/31/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/31/20243:05PMBusiness WireEvolus Reports Second Quarter 2024 Results and Raises Full Year Revenue GuidanceNASDAQ:EOLSEvolus Inc
07/31/20247:00AMBusiness WireEvolus to Hold Investor Day on September 12, 2024NASDAQ:EOLSEvolus Inc
07/30/20247:00AMBusiness WireEvolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in AustraliaNASDAQ:EOLSEvolus Inc
07/25/20247:00AMBusiness WireEvolus to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:EOLSEvolus Inc
07/17/20247:00AMBusiness WireEvolus to Report Second Quarter Financial Results on July 31, 2024NASDAQ:EOLSEvolus Inc
07/01/20247:00AMBusiness WireEvolus Announces Appointment of Albert G. White III to Board of DirectorsNASDAQ:EOLSEvolus Inc
06/24/20247:00AMBusiness WireEvolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler ProductsNASDAQ:EOLSEvolus Inc
06/12/20247:00AMBusiness WireEvolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in SpainNASDAQ:EOLSEvolus Inc
06/11/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
06/07/20244:00PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS